MERTK and breast carcinoma: Based on the use of Mertk-/-V1 mice, it was also surmised that inhibition of macrophage efferocytosis due to MERTK loss of function results in decreased tumor growth and increased tumor-free survival (TFS) in E0771 murine breast cancer model (Davra et al., 2021).